BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 9338941)

  • 1. Safety of combination therapy with hydroxychloroquine, gold sodium thiomalate and methotrexate in early rheumatoid arthritis.
    Biasi D; Caramaschi P; Carletto A; Pacor ML; Bambara LM
    Rev Rhum Engl Ed; 1997; 64(7-9):521-2. PubMed ID: 9338941
    [No Abstract]   [Full Text] [Related]  

  • 2. Rheumatoid arthritis: limiting the damage.
    Hosie G
    Nurs Times; 2002 Mar 28-Apr 1; 98(13):34-6. PubMed ID: 11974758
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications.
    O'Dell JR; Haire CE; Erikson N; Drymalski W; Palmer W; Eckhoff PJ; Garwood V; Maloley P; Klassen LW; Wees S; Klein H; Moore GF
    N Engl J Med; 1996 May; 334(20):1287-91. PubMed ID: 8609945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drugs for rheumatoid arthritis.
    Med Lett Drugs Ther; 2000 Jul; 42(1082):57-64. PubMed ID: 10887424
    [No Abstract]   [Full Text] [Related]  

  • 5. [Combined drug therapy in recent-onset rheumatoid arthritis. Evaluation after 1 year of treatment].
    Biasi D; Caramaschi P; Carletto A; Pacor ML; Zeminian S; Bambara LM
    Recenti Prog Med; 1998 Jan; 89(1):14-7. PubMed ID: 9549387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Slow acting anti-rheumatic drugs in the treatment of rheumatoid arthritis.
    Kovarsky J
    Tex Med; 1985 Sep; 81(9):35-9. PubMed ID: 3931276
    [No Abstract]   [Full Text] [Related]  

  • 7. Termination of slow acting antirheumatic therapy in rheumatoid arthritis: a 14-year prospective evaluation of 1017 consecutive starts.
    Wolfe F; Hawley DJ; Cathey MA
    J Rheumatol; 1990 Aug; 17(8):994-1002. PubMed ID: 1976811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use.
    Proudman SM; Keen HI; Stamp LK; Lee AT; Goldblatt F; Ayres OC; Rischmueller M; James MJ; Hill CL; Caughey GE; Cleland LG
    Semin Arthritis Rheum; 2007 Oct; 37(2):99-111. PubMed ID: 17391739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-chikungunya chronic arthritis--our experience with DMARDs over two year follow up.
    Ganu MA; Ganu AS
    J Assoc Physicians India; 2011 Feb; 59():83-6. PubMed ID: 21751641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate: vital new information about a middle aged drug.
    Giannini EH
    J Rheumatol; 2002 Oct; 29(10):2031-3. PubMed ID: 12375307
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of rheumatoid arthritis.
    Stohl W; Arkfeld DG
    N Engl J Med; 1996 Sep; 335(11):821-2; author reply 822-3. PubMed ID: 8778593
    [No Abstract]   [Full Text] [Related]  

  • 12. A good response to early DMARD treatment of patients with rheumatoid arthritis in the first year predicts remission during follow up.
    Verstappen SM; van Albada-Kuipers GA; Bijlsma JW; Blaauw AA; Schenk Y; Haanen HC; Jacobs JW;
    Ann Rheum Dis; 2005 Jan; 64(1):38-43. PubMed ID: 15130899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etanercept in combination with sulfasalazine, hydroxychloroquine, or gold in the treatment of rheumatoid arthritis.
    O'Dell JR; Petersen K; Leff R; Palmer W; Schned E; Blakely K; Haire C; Fernandez A
    J Rheumatol; 2006 Feb; 33(2):213-8. PubMed ID: 16358366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DMARDs in the treatment of rheumatoid arthritis: current agents and future developments.
    Simon LS
    Int J Clin Pract; 2000 May; 54(4):243-9. PubMed ID: 10912314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early rheumatoid arthritis: combination therapy of doxycycline plus methotrexate versus methotrexate monotherapy.
    Alarcón GS
    Nat Clin Pract Rheumatol; 2006 Jun; 2(6):296-7. PubMed ID: 16932705
    [No Abstract]   [Full Text] [Related]  

  • 16. Methotrexate, hydroxychloroquine, and intramuscular gold in rheumatoid arthritis: relative area under the curve effectiveness and sequence effects.
    Hurst S; Kallan MJ; Wolfe FJ; Fries JF; Albert DA
    J Rheumatol; 2002 Aug; 29(8):1639-45. PubMed ID: 12180722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of rheumatoid arthritis.
    Zurier RB; DeMarco DM; Liu NY
    N Engl J Med; 1996 Sep; 335(11):822; author reply 822-3. PubMed ID: 8778595
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term followup of patients receiving combined therapy with cyclosporine and methotrexate.
    González-Gay MA; Blanco R; García-Porrúa C; Ibáñez D; Vázquez-Caruncho M; Sánchez-Bursón J; Marenco JL
    Arthritis Rheum; 1998 Sep; 41(9):1703-4. PubMed ID: 9751107
    [No Abstract]   [Full Text] [Related]  

  • 19. Triple therapy in early active rheumatoid arthritis: a randomized, single-blind, controlled trial comparing step-up and parallel treatment strategies.
    Saunders SA; Capell HA; Stirling A; Vallance R; Kincaid W; McMahon AD; Porter DR
    Arthritis Rheum; 2008 May; 58(5):1310-7. PubMed ID: 18438851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How aggressive should initial therapy for rheumatoid arthritis be? Factors associated with response to 'non-aggressive' DMARD treatment and perspective from a 2-yr open label trial.
    Matteson EL; Weyand CM; Fulbright JW; Christianson TJ; McClelland RL; Goronzy JJ
    Rheumatology (Oxford); 2004 May; 43(5):619-25. PubMed ID: 14983105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.